09:52 AM EST - TerrAscend Canada Inc. : And MediPharm Labs Corp. have entered into a multi-year supply agreement, whereby MediPharm Labs will supply TerrAscend with approximately $27 million of high-quality private label cannabis distillate, over 24-months commencing September 2019, and, subject to certain renewal and purchase options, potentially up to $192 million over 36-months to September 2022. In connection with Canadian Cannabis 2.0 legalization, with amended regulations coming into force on October 17, 2019, TerrAscend will use this supply to support the production and launch of its exciting portfolio of branded products in Canada this fall. TerrAscend Canada Inc.
shares TER:CNX are trading up $0.25 at $5.77.
